BioPharmSignal logoBioPharmSignal

Biotech News

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics (STIM)NeuroneticsCompany update

MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the granting of

Related news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

OMOutset Medical2026-07-02 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DCTHDelcath Systems2026-07-16 20:01 EST

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PLSEPulse Biosciences2026-07-15 20:05 EST

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LUNGPulmonx2026-06-01 20:05 EST

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RXSTRxSight2026-07-26 20:00 EST

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

XAIRBeyond Air2026-06-01 12:00 EST

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

View all latest news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-31 21:00 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

STIMNeuronetics2026-07-28 12:32 EST

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-07-20 20:05 EST

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Stock data

Close
2.25 USD
Market cap
108.56M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States